To Reverse or Not to Reverse?

Anesthesiology

Volumn 125, Issue 4, 2016, Pages 611-614

  Murphy, Glenn S ^a   Kopman, Aaron F ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; CHOLINESTERASE INHIBITOR; CISATRACURIUM; MUSCARINIC RECEPTOR BLOCKING AGENT; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; VECURONIUM;

ANESTHESIOLOGICAL PROCEDURE; DISEASE ASSOCIATION; DRUG INDICATION; DRUG USE; INCIDENCE; INTUBATION; MORTALITY; NEUROMUSCULAR BLOCKADE REVERSAL; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; OXYGEN DESATURATION; PATIENT SAFETY; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE RESIDUAL NEUROMUSCULAR BLOCK; PRIORITY JOURNAL; RECOVERY ROOM; RESPIRATORY FAILURE; REVIEW; TREATMENT FAILURE;

EID: 84982830428     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000001280     Document Type: Review

References (33)

1. Viby-Mogensen J, Jørgensen BC, Ording H: Residual curarization in the recovery room. Anesthesiology 1979; 50:539-41
2. Beemer GH, Rozental P: Postoperative neuromuscular function. Anaesth Intensive Care 1986; 14:41-5
3. Andersen BN, Madsen JV, Schurizek BA, Juhl B: Residual curarisation: A comparative study of atracurium and pancuronium. Acta Anaesthesiol Scand 1988; 32:79-81
4. Bevan DR, Smith CE, Donati F: Postoperative neuromuscular blockade: A comparison between atracurium, vecuronium, and pancuronium. Anesthesiology 1988; 69:272-6
5. Miller RD: How should residual neuromuscular blockade be detected? Anesthesiology 1989; 70:379-80
6. Bulka CM, Terekhov MA, Martin BJ, Dmochowski RR, Hayes RM, Ehrenfeld JM: Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia. Anesthesiology 2016; 125:647-55
7. Beecher HK, Todd DP: A study of the deaths associated with anesthesia and surgery: Based on a study of 599, 548 anesthesias in ten institutions 1948-1952, inclusive. Ann Surg 1954; 140:2-35
8. Harrison GG: Death attributable to anaesthesia. A 10-year survey (1967-1976). Br J Anaesth 1978; 50:1041-6
9. Cooper AL, Leigh JM, Tring IC: Admissions to the intensive care unit after complications of anaesthetic techniques over 10 years.1.The first 5 years. Anaesthesia 1989; 44:953-8
10. Pedersen T, Viby-Mogensen J, Ringsted C: Anaesthetic practice and postoperative pulmonary complications. Acta Anaesthesiol Scand 1992; 36:812-8
11. Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, Ehrenfeld JM, Martinez EA, Kurth T, Eikermann M: Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: Prospective propensity score matched cohort study. BMJ 2012; 345:e6329
12. McLean DJ, Diaz-Gil D, Farhan HN, Ladha KS, Kurth T, Eikermann M: Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology 2015; 122:1201-13
13. Arbous MS, Meursing AE, van Kleef JW, de Lange JJ, Spoormans HH, Touw P, Werner FM, Grobbee DE: Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005; 102:257-68; quiz 491-2
14. Ledowski T, Falke L, Johnston F, Gillies E, Greenaway M, De Mel A, Tiong WS, Phillips M: Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: Sugammadex, neostigmine or no reversal. Eur J Anaesthesiol 2014; 31:423-9
15. Sasaki N, Meyer MJ, Malviya SA, Stanislaus AB, MacDonald T, Doran ME, Igumenshcheva A, Hoang AH, Eikermann M: Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: A prospective study. Anesthesiology 2014; 121:959-68
16. Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M: Residual curarization in the recovery room after vecuronium. Br J Anaesth 2000; 84:394-5
17. Maybauer DM, Geldner G, Blobner M, Pühringer F, Hofmockel R, Rex C, Wulf HF, Eberhart L, Arndt C, Eikermann M: Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium. Anaesthesia 2007; 62:12-7
18. Pietraszewski P, Gaszyński T: Residual neuromuscular block in elderly patients after surgical procedures under general anaesthesia with rocuronium. Anaesthesiol Intensive Ther 2013; 45:77-81
19. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ: A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010; 111:110-9
20. Debaene B, Plaud B, Dilly MP, Donati F: Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98:1042-8
21. Viby-Mogensen J, Jensen NH, Engbaek J, Ording H, Skovgaard LT, Chraemmer-Jørgensen B: Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985; 63:440-3
22. Brull SJ, Silverman DG: Visual and tactile assessment of neuromuscular fade. Anesth Analg 1993; 77:352-5
23. Meyer MJ, Bateman BT, Kurth T, Eikermann M: Neostigmine reversal doesn't improve postoperative respiratory safety. BMJ 2013; 346:f1460
24. Herbstreit F, Zigrahn D, Ochterbeck C, Peters J, Eikermann M: Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2010; 113:1280-8
25. Payne JP, Hughes R, Al Azawi S: Neuromuscular blockade by neostigmine in anaesthetized man. Br J Anaesth 1980; 52:69-76
26. Goldhill DR, Wainwright AP, Stuart CS, Flynn PJ: Neostigmine after spontaneous recovery from neuromuscular blockade. Effect on depth of blockade monitored with train-of-four and tetanic stimuli. Anaesthesia 1989; 44:293-9
27. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, Krintel JJ: Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41:1095-103
28. Kirkegaard H, Heier T, Caldwell JE: Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 2002; 96:45-50
29. Kim KS, Cheong MA, Lee HJ, Lee JM: Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia. Anesth Analg 2004; 99:1080-5
30. Fuchs-Buder T, Meistelman C, Alla F, Grandjean A, Wuthrich Y, Donati F: Antagonism of low degrees of atracurium-induced neuromuscular blockade: Dose-effect relationship for neostigmine. Anesthesiology 2010; 112:34-40
31. Fuchs-Buder T, Baumann C, De Guis J, Guerci P, Meistelman C: Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial. Eur J Anaesthesiol 2013; 30:594-8
32. Schaller SJ, Fink H, Ulm K, Blobner M: Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology 2010; 113:1054-60
33. Choi ES, Oh AY, Seo KS, Hwang JW, Ryu JH, Koo BW, Kim BG: Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium. Anaesthesia 2016; 71:443-9